Safety, Pharmacokinetics, and Pharmacodynamics of Single-Dose Programmed Cell Death Protein 1 Inhibitor, Budigalimab, in People With HIV-1 With Antiretroviral Therapy-Suppressed Viral Load. (academic.oup.com)

Authors: Vaidya TR … Mostafa NM Journal: Journal of Infectious Diseases Published: 2026-04-07 DOI: https://doi.org/10.1093/infdis/jiag142